| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgement to referees
|
,
|
|
1999
|
43 |
6 |
p. 525-526
|
artikel
|
| 2 |
Activity of dolastatin 10 against small-cell lung cancer in vitro and in vivo: induction of apoptosis and bcl-2 modification
|
Kalemkerian, Gregory P.
|
|
1999
|
43 |
6 |
p. 507-515
|
artikel
|
| 3 |
A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancer
|
Subramanyan, Smitha
|
|
1999
|
43 |
6 |
p. 497-502
|
artikel
|
| 4 |
A phase II study of irinotecan and infusional cisplatin with recombinant human granulocyte colony-stimulating factor support for advanced non-small-cell lung cancer
|
Mori, Kiyoshi
|
|
1999
|
43 |
6 |
p. 467-470
|
artikel
|
| 5 |
Doxorubicin-induced congestive heart failure in elderly patients with metastatic breast cancer, with long-term follow-up: the M.D. Anderson experience
|
Ibrahim, Nuhad K.
|
|
1999
|
43 |
6 |
p. 471-478
|
artikel
|
| 6 |
Endocrinological and clinical evaluation of two depot formulations of leuprolide acetate in pre- and perimenopausal breast cancer patients
|
Boccardo, Francesco
|
|
1999
|
43 |
6 |
p. 461-466
|
artikel
|
| 7 |
Erratum: Cancer Chemother Pharmacol (1998) 42: 300–306
|
,
|
|
1999
|
43 |
6 |
p. 522
|
artikel
|
| 8 |
Erratum: Cancer Chemother Pharmacol (1993) 32: 39–45
|
,
|
|
1999
|
43 |
6 |
p. 523
|
artikel
|
| 9 |
Erratum: Cancer Chemother Pharmacol (1999) 43: 1–7
|
,
|
|
1999
|
43 |
6 |
p. 524
|
artikel
|
| 10 |
Interpatient variability in bioavailability of the intravenous formulation of topotecan given orally to children with recurrent solid tumors
|
Zamboni, William C.
|
|
1999
|
43 |
6 |
p. 454-460
|
artikel
|
| 11 |
Paclitaxel in the treatment of human immunodeficiency virus 1-associated Kaposi's sarcoma – drug-drug interactions with protease inhibitors and a nonnucleoside reverse transcriptase inhibitor: a case report study
|
Nannan Panday, Vinodh R.
|
|
|
43 |
6 |
p. 516-519
|
artikel
|
| 12 |
Paclitaxel in the treatment of human immunodeficiency virus 1-associated Kaposi's sarcoma – drug-drug interactions with protease inhibitors and a nonnucleoside reverse transcriptase inhibitor: a case report study
|
Nannan Panday, Vinodh R.
|
|
1999
|
43 |
6 |
p. 516-519
|
artikel
|
| 13 |
Phase II study of KRN8602, 3′-deamino-3′-morpholino- 13-deoxo-10-hydroxycarminomycin hydrochloride, MX2 · HCl in patients with metastatic breast cancer
|
Katsumata, Noriyuki
|
|
1999
|
43 |
6 |
p. 441-444
|
artikel
|
| 14 |
Phase I study of AG 331, a novel thymidylate synthase inhibitor, in patients with refractory solid tumors
|
Koda, Robert T.
|
|
1999
|
43 |
6 |
p. 489-496
|
artikel
|
| 15 |
Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats
|
Egorin, Merrill J.
|
|
1999
|
43 |
6 |
p. 445-453
|
artikel
|
| 16 |
Possible excretion of etoposide via the intestinal mucosa
|
Perdaems, Nathalie
|
|
1999
|
43 |
6 |
p. 520-521
|
artikel
|
| 17 |
Thirteen-week oral toxicity study of difluoromethylornithine in combination with tamoxifen citrate in female dogs
|
Brown, Alan P.
|
|
1999
|
43 |
6 |
p. 479-488
|
artikel
|
| 18 |
Two different schedules for integrating filgrastim as adjuvant therapy in the treatment of patients with advanced stage Hodgkin's lymphoma receiving MOPP/ABV hybrid chemotherapy
|
Cantin, Guy
|
|
1999
|
43 |
6 |
p. 503-506
|
artikel
|
Tijdschrift beschrijving